Latisse Eyelash Growth Stimulant
Latisse (bimatoprost ophthalmic solution 0.03%) is a new prescription product that promotes eyelash growth. In late December, the FDA approved Latisse for treating eyelash hypotrichosis. (poor or stunted growth) This same drug, known as Lumigan in ophthalmologic use, first received FDA approval in 2001 for lowering intraocular pressure in patients with open-angle glaucoma and ocular Read More…
